BlackRock has filed with the US SEC to launch the iShares Bitcoin Managed Protection ETF, which offers investors upside exposure to Bitcoin gains through its flagship iShares Bitcoin Trust ETF (IBIT) while providing a layer of downside protection. This new fund aims to limit losses during market downturns and will build on the existing IBIT structure rather than holding Bitcoin directly. The move expands investor options, allowing choices between raw Bitcoin exposure, income generation, and now downside protection within BlackRock's Bitcoin ETF offerings. Key details like fees, ticker, and launch date are pending SEC approval and disclosure by BlackRock.
BlackRock's filing for the iShares Bitcoin Managed Protection ETF offers new context for digital asset investors. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 20, 2026 04:42 WIB: of 50 major cryptocurrencies priced on Pluang, 46 rose and 3 fell today. Notable movers include BAL (Balancer) at Rp16.297 with a 1-day change of +11.14%, EOS (EOS.IO) at Rp12.649 up 8.13%, and DOT (Polkadot) at Rp20.410 rising 7.63%.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...
